V Michael Holers

This inventor holds 21 USPTO granted patents and 10 published patent applications and 5 EPO patents. Top assignees: University of Colorado, Musc Foundation for Research Development, Alexion Pharmaceuticals, Inc.. Active years: 2010-2022.

USPTO Granted Patents = 21 (Patent Applications = 10)

% Patents Active = 76.2

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 2.8

ph-index = 5

Forward Citations = 74(Granted Patents)

Location History:

Aurora, CO (US) (2019 - 2021)
Denver, CO (US) (2010 - 2022)

Company Filing History:

17 out of 1,447

University of Colorado

patents

8 out of 178

Musc Foundation for Research Development

patents

2 out of 199

Alexion Pharmaceuticals, Inc.

patents

4. 1 out of 3,795

Johns Hopkins University

patents

5. 1 out of 90

National Jewish Health

patents

6. 1 out of 1

Taligen Therapeutics, Inc.

patent

where one patent can have more than one assignee

Years Active: 2010-2022

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE49339 - Antibodies to the C3D fragment of complement component 3 (2022-12-19),

2. 11407820 - Modulating the alternative complement pathway (2022-08-09),

3. 11191851 - Anti-C3d antibody conjugates and methods of detecting complement activation (2021-12-07),

4. 10413620 - Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging (2019-09-17),

5. 10278986 - Antibody-siRNA conjugates and uses therefor (2019-05-07),

6. 10239937 - Treatment of paroxysmal nocturnal hemoglobinuria, hemolytic anemias and disease states involving intravascular and extravascular hemolysis (2019-03-26),

7. 10233235 - Modulating the alternative complement pathway (2019-03-19),

8. 9815890 - Antibodies to the C3d fragment of complement component 3 (2017-11-14),

9. 9650447 - Complement receptor 2 (CR2) targeting groups (2017-05-16),

10. 9259488 - Anti-C3d antibody conjugates and methods of detecting complement activation (2016-02-16),

11. 9212212 - Targeting complement factor H for treatment of diseases (2015-12-15),

12. 9096677 - Humaneered anti-factor B antibody (2015-08-04),

13. 8937046 - Modulating the alternative complement pathway (2015-01-20),

14. 8858945 - Three-dimensional structure of complement receptor type 2 and uses thereof (2014-10-14),

15. 8840868 - Non-invasive detection of complement-mediated inflammation using CR2-targeted nanoparticles (2014-09-23),

Title: The Innovative Journey of V Michael Holers

Introduction: V Michael Holers is a distinguished inventor based in Denver, Colorado. His groundbreaking work in the field of inventions has significantly contributed to advancements in various industries.

Latest Patents: V Michael Holers holds several patents in the areas of biotechnology and medical devices, showcasing his commitment to innovation and problem-solving.

Career Highlights: With a career spanning several decades, V Michael Holers has established himself as a leading figure in the world of inventors. His innovative solutions have garnered recognition and praise from peers and professionals alike.

Collaborations: Throughout his career, V Michael Holers has collaborated with top research institutions, universities, and companies to bring his inventions to life. His ability to work in multidisciplinary teams has led to the development of cutting-edge technologies.

Conclusion: V Michael Holers' passion for innovation and his dedication to pushing the boundaries of what is possible make him a true pioneer in the world of inventions. His work continues to inspire future generations of inventors to think creatively and strive for excellence in their pursuits.